Targeted toxins in pain

Advanced Drug Delivery Reviews

Volumn 55, Issue 8, 2003, Pages 1043-1054

  Wiley, Ronald G ^a,c   Lappi, Douglas A ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b Advanced Targeting Systems   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dermorphin; Dopamine hydroxylase; Immunotoxin; Suicide transport

Indexed keywords

ENZYMES; GENES; NEUROSURGERY; VIRUSES;

NEURAL LESIONS;

DRUG PRODUCTS;

ABRIN; CHOLERA TOXIN; DERMORPHIN; IMMUNOTOXIN; LECTIN; MODECCIN; NEUROPEPTIDE; OREXIN B; RIBOSOME INACTIVATING PROTEIN; RICIN A; SAPORIN; SUBSTANCE P; VOLKENSIN;

ANTINOCICEPTION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG TARGETING; INJECTION; MOLECULAR DYNAMICS; NERVE FIBER; NEUROSURGERY; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SYNAPSE;

EID: 0142043857     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00102-9     Document Type: Article

References (96)

1. Wiley R.G., Blessing W.W., Reis D.J. Suicide transport: destruction of neurons by retrograde transport of ricin, abrin, and modeccin. Science. 216:1982;889-890.
2. Wiley R.G., Kline R.H. IV. Neuronal lesioning with axonally transported toxins. J. Neurosci. Methods. 103:2000;73-82.
3. Lappi D.A., Wiley R.G. Entering through the doors of perception: characterization of a highly selective substance P receptor-targeted toxin. Neuropeptides. 34:2000;323-328.
4. Wiley R.G. Neuropeptide-toxin conjugates in pain research and treatment. Reg. Anesth. Pain Med. 25:2000;546-548.
5. Wiley R.G. Targeting toxins to neural antigens and receptors. Semin. Cancer Biol. 7:1996;71-77.
6. Wiley R.G., Lappi D.A. Suicide Transport and Immunolesioning. 1994;Molecular Biology Intelligence Unit, R.G. Landes Co. Austin, TX.
7. Wiley R.G. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci. 15:1992;285-290.
8. Wiley R.G., Oeltmann T.N. Ricin and related plant toxins: mechanism of action and neurobiological applications. Keeler R.F., Tu A.T. Toxicology of Plant and Fungal Compounds. Handbook of Natural Toxins. vol. 6:1991;243-268 Marcel Dekker, New York.
9. Kelly R.M., Strick P.L. Rabies as a transneuronal tracer of circuits in the central nervous system. J. Neurosci. Methods. 103:2000;63-71.
10. Bearer E.L., Breakefield X.O., Schuback D., Reese T.S., LaVail J.H. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc. Natl. Acad. Sci. USA. 97:2000;8146-8150.
11. Ohka S., Yang W.X., Terada E., Iwasaki K., Nomoto A. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology. 250:1998;67-75.
12. Figueiredo D.M., Hallewell R.A., Chen L.L., Fairweather N.F., Dougan G., Savitt J.M., Parks D.A., Fishman P.S. Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport. Exp. Neurol. 145:1997;546-554.
13. Halpern J.L., Neale E.A. Neurospecific binding, internalization, and retrograde axonal transport. Curr. Top. Microbiol. Immunol. 195:1995;221-241.
14. Stirpe F., Gasperi-Campani A., Barbieri L., Falasca A., Abbondanza A., Stevens W.A. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort) of Agrostemma githago L. (corn cockle) and of Asparagus officinalis (asparagus) and from the latex of Hura crepitans L. (sandbox tree). Biochem. J. 216:1983;617-625.
15. Eiklid K., Olsnes S., Pihl A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp. Cell Res. 126:1980;321-326.
16. Nichols M.L., Allen B.J., Rogers S.D., Ghilardi J.R., Honore P., Luger N.M., Finke M.P., Li J., Lappi D.A., Simone D.A., Mantyh P.W. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science. 286:1999;1558-1561.
17. Heckers S., Ohtake T., Wiley R.G., Lappi D.A., Geula C., Mesulam M.M. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14:1994;1271-1289.
18. Milner T.A., Wiley R.G., Kurucz O.S., Prince S.R., Pierce J.P. Selective changes in hippocampal neuropeptide Y neurons following removal of the cholinergic septal inputs. J. Comp. Neurol. 386:1997;46-59.
19. Zhang Z.J., Lappi D.A., Wreim C.C., Milner T.A., Wiley R.G. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons. Brain Res. 800:1998;198-206.
20. Milner T.A., Hammel J.R., Ghorbani T.T., Wiley R.G., Pierce J.P. Septal cholinergic deafferentation of the dentate gyrus results in a loss of a subset of neuropeptide Y somata and an increase in synaptic area on remaining neuropeptide Y dendrites. Brain Res. 831:1999;322-336.
21. Ling E.A., Wen C.Y., Shieh J.Y., Yick T.Y., Leong S.K. Neuroglial response to neuron injury. A study using intraneural injection of Ricinus communis agglutinin-60. J. Anat. 160:1989;204-216.
22. Ling E.A., Leong S.K. Effects of intraneural injection of Ricinus communis agglutinin-60 into the rat vagus nerve. J. Neurocytol. 16:1987;373-387.
23. Yamamoto T., Iwasaki Y., Konno H., Kudo H. Primary degeneration of motor neurons by toxic lectins conveyed from the peripheral nerve. J. Neurol. Sci. 70:1985;327-337.
24. Yamamoto T., Iwasaki Y., Konno H. Experimental sensory ganglionectomy by way of suicide axoplasmic transport. J. Neurosurg. 60:1984;108-114.
25. Yamamoto T., Iwasaki Y., Konno H. Retrograde axoplasmic transport of toxic lectins is useful for transganglionic tracings of the peripheral nerve. Brain Res. 274:1983;325-328.
26. Helke C.J., Charlton C.G., Wiley R.G. Studies on the cellular localization of spinal cord substance P receptors. Neuroscience. 19:1986;523-533.
27. Helke C.J., Charlton C.G., Wiley R.G. Suicide transport of ricin demonstrates the presence of substance P receptors on medullary somatic and autonomic motor neurons. Brain Res. 328:1985;190-195.
28. Cusick C.G., Wall J.T., Whiting J.H. Jr., Wiley R.G. Temporal progression of cortical reorganization following nerve injury. Brain Res. 537:1990;355-358.
29. Wall J.T., Cusick C.G., Migani-Wall S.A., Wiley R.G. Cortical organization after treatment of a peripheral nerve with ricin: an evaluation of the relationship between sensory neuron death and cortical adjustments after nerve injury. J. Comp. Neurol. 277:1988;578-592.
30. Blumenkopf B., Lipman J.J. Studies in autotomy: its pathophysiology and usefulness as a model of chronic pain. Pain. 45:1991;203-209.
31. Brandner M.D., Buncke H.J., Campagna-Pinto D. Experimental treatment of neuromas in the rat by retrograde axoplasmic transport of ricin with selective destruction of ganglion cells. J. Hand Surg. (USA). 14:1989;710-714.
32. Cummings J.F., Fubini S.L., Todhunter R.J. Attempts to prevent equine post neurectomy neuroma formation through retrograde transport of two neurotoxins, doxorubicin and ricin. Equine Vet. J. 20:1988;451-456.
33. Nennesmo I., Kristensson K. Effects of retrograde axonal transport of Ricinus communis agglutinin I on neuroma formation. Acta Neuropathol. (Berl.). 70:1986;279-283.
34. Wiley R.G., Stirpe F., Thorpe P., Oeltmann T.N. Neuronotoxic effects of monoclonal anti-Thy 1 antibody (OX7) coupled to the ribosome inactivating protein, saporin, as studied by suicide transport experiments in the rat. Brain Res. 505:1989;44-54.
35. Vogt B.A., Wiley R.G., Jensen E.L. Localization of mu and delta opioid receptors to anterior cingulate afferents and projection neurons: an input/output model of mu regulation 22. Exp. Neurol. 135:1995;83-92.
36. Salo P.T., Hogervorst T., Seerattan R.A., Rucker D., Bray R.C. Selective joint denervation promotes knee osteoarthritis in the aging rat. J. Orthop. Res. 20:2002;1256-1264.
37. Salo P.T., Theriault E., Wiley R.G. Selective ablation of rat knee joint innervation with injected immunotoxin: a potential new model for the study of neuropathic arthritis. J. Orthop. Res. 15:1997;622-628.
38. Wiley R.G., Oeltmami T.N., Lappi D.A. Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res. 562:1991;149-153.
39. Wiley R.G., Berbos T.G., Deckwerth T.L., Jolmson E.M.J., Lappi D.A. Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease. J. Neurol. Sci. 128:1995;157-166.
40. Leanza G., Nilsson O.G., Wiley R.G., Bjorklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur. J. Neurosci. 7:1995;329-343.
41. Paqueron X., Li X., Eisenach J.C. P75-expressing elements are necessary for antiallodynic effects of spinal clonidine and neostigmine. Neuroscience. 102:2001;681-686.
42. Wrenn C.C., Picklo M.J., Lappi D.A., Robertson D., Wiley R.G. Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Brain Res. 740:1996;175-184.
43. Picklo M.J., Wiley R.G., Lappi D.A., Robertson D.A. Noradrenergic lesioning using an immunotoxin against dopamine beta-hydroxylase. Brain Res. 666:1995;195-200.
44. Picklo M.J., Wiley R.G., Lonce S., Lappi D.A., Robertson D. Anti-dopamine β-hydroxylase immunotoxin-induced sympathectomy in adult rats. J. Pharmacol. Exp. Ther. 275:1995;1003-1010.
45. Blessing W.E., Lappi D.A., Wiley R.G. Destruction of locus coeruleus neuronal perikarya after injection of anti-dopamine-B-hydroxylase immunotoxin into the olfactory bulb of the rat. Neurosci. Lett. 243:1998;85-88.
46. Kingery W.S., Agashe G.S., Guo T.Z., Sawamura S., Davies M.F., Clark J.D., Kobilka B.K., Maze M. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha 1 adrenoceptors mediate pronociception. Anesthesiology. 96:2002;367-374.
47. Sawamura S., Kingery W.S., Davies M.F., Agashe G.S., Clark J.D., Kobilka B.K., Hashimoto T., Maze M. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors 16. J. Neurosci. 20:2000;9242-9251.
48. Vogt L.J., Sim-Selley L.J., Childers S.R., Wiley R.G., Vogt B.A. Colocalization of mu-opioid receptors and activated G-proteins in rat cingulate cortex. J. Pharmacol. Exp. Ther. 299:2001;840-848.
49. Taylor B.K., Roderick R.E., Basbaum A.I. Brainstem noradrenergic control of nociception is abnormal in the spontaneously hypertensive rat. Neurosci. Lett. 291:2000;139-142.
50. Rohde D.S., Basbaum A.I. Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat. J. Neurosci. 18:1998;4393-4402.
51. Martin W.J., Gupta N.K., Loo C.M., Rohde D.S., Basbaum A.I. Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Pain. 80:1999;57-65.
52. Li X., Conklin D., Ma W., Zhu X., Eisenach J.C. Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain. 97:2002;117-125.
53. Vulchanova L., Olson T.H., Stone L.S., Riedl M.S., Elde R., Honda C.N. Cytotoxic targeting of isolectin IB4-binding sensory neurons. Neuroscience. 108:2001;143-155.
54. Jasmin L., Janni G., Moallem T.M., Lappi D.A., Ohara P.T. Schwann cells are removed from the spinal cord after effecting recovery from paraplegia. J. Neurosci. 20:2000;9215-9223.
55. Llewellyn-Smith I.J., Martin C.L., Arnolda L.F., Minson J.B. Tracer-toxins: cholera toxin B-saporin as a model. J. Neurosci. Methods. 103:2000;83-90.
56. Llewellyn-Smith I.J., Martin C.L., Arnolda L.F., Minson J.B. Retrogradely transported CTB-saporin kills sympathetic preganglionic neurons. Neuroreport. 10:1999;307-312.
57. Mantyh P.W., Allen C.J., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E. Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;2622-2626.
58. Wiley R.G., Lappi D.A. Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats. Neurosci. Lett. 230:1997;97-100.
59. 11] substance P-saporin. Neurosci. Lett. 277:1999;1-4.
60. Honoré P., Menning P.M., Rogers S.D., Nichols M.L., Basbaum A.I., Besson J.M., Mantyh P.W. Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J. Neurosci. 19:1999;7670-7678.
61. Allen B.J., Rogers S.D., Ghilardi J.R., Menning P.M., Kuskowski M.A., Basbaum A.I., Simone D.A., Mantyh P.W. Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J. Neurosci. 17:1997;5921-5927.
62. Abbadie C., Brown J.L., Mantyh P.W., Basbaum A.I. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience. 70:1996;201-209.
63. Mantyh P.W., DeMaster E., Malhotra A., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science. 268:1995;1629-1632.
64. Nichols M.L., Allen B.J., Rogers S.D., Ghilardi J.R., Honore P., Luger N.M., Finke M.P., Li J., Lappi D.A., Simone D.A., Mantyh P.W. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science. 286:1999;1558-1561.
65. Mantyh P.W., Rogers S.D., Honore P., Allen B.J., Ghilardi J.R., Li J., Daughters R.S., Lappi D.A., Wiley R.G., Simone D.A. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science. 278:1997;275-279.
66. Vierck C. Jr., Kline IV R.H., Wiley R.G. Intrathecal substance P-saporin attenuates escape from nociceptive thermal stimuli. Neuroscience. 119:2003;223-232.
67. Suzuki R., Morcuende S., Webber M., Hunt S.P., Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat. Neurosci. 5:2002;1319-1326.
68. Khasabov S.G., Rogers S.D., Ghilardi J.R., Peters C.M., Mantyh P.W., Simone D.A. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J. Neurosci. 22:2002;9086-9098.
69. Friedrich M.J. Loss of nerve: a molecular approach to better treatment of chronic pain. J. Am. Med. Assoc. 283:2000;187-188.
70. Benoliel R., Eliav E., Mannes A.J., Caudle R.M., Leeman S., Iadarola M.J. Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain. 79:1999;243-253.
71. Fisher C.E., Sutherland J.A., Krause J.E., Murphy J.R., Leeman S.E., van der Spek J.C. Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptors. Proc. Natl. Acad. Sci. USA. 93:1996;7341-7345.
72. Simons C.T., Gogineni A.G., Iodi C.M., Carstens E. Reduced aversion to oral capsaicin following neurotoxic destruction of superficial medullary neurons expressing NK-1 receptors. Brain Res. 945:2002;139-143.
73. Gaudriault G., Zsurger N., Vincent J.P. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors. J. Neurochem. 68:1997;813-819.
74. Krumins S.A. Characterization of dermorphin binding to membranes of rat brain and heart. Neuropeptides. 9:1987;93-102.
75. Giagnoni G., Mennuni L., Pecora N., Basilico L., Parolaro D., Gori E. Binding studies of dermorphin and its L-form on rat brain opioid receptors. Pharmacol. Res. Commun. 19:1987;173-181.
76. Marvizón J.C.G., Grady E.F., Waszak-McGee J., Mayer E.A. Internalization of μ-opioid receptors in rat spinal cord slices. Neuroreport. 10:1999;2329-2334.
77. McConalogue K., Grady E.F., Minnis J., Balestra B., Tonini M., Brecha N.C., Bunriett N.W., Sternini C. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-l and endomorphin-2. Neuroscience. 90:1999;1051-1059.
78. Burford N.T., Tolbert L.M., Sadee W. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur. J. Pharmacol. 342:1998;123-126.
79. Burgess S.E., Gardell L.R., Ossipov M.H., Malan T.P. Jr., Vanderah T.W., Lai J., Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 22:2002;5129-5136.
80. Porreca F., Burgess S.E., Gardell L.R., Vanderah T.W., Malan T.P. Jr., Ossipov M.H., Lappi D.A., Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J. Neurosci. 21:2001;5281-5288.
81. Miller S.A., Lappi D.A., Wiley R.G. Enhanced morphine analgesia after spinal dermorphin-saporin. Soc. Neurosci. 27:2002;218.1.
82. Gerashchenko D., Blanco-Centurion C., Greco M.A., Shiromani P.J. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience. 116:2003;223-235.
83. Gerashchenko D., Kohls M.D., Greco M., Waleh N.S., Salin-Pascual R. R., Kilduff T.S., Lappi D.A., Shiromani P.J. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J. Neurosci. 21:2001;7273-7283.
84. Maciejewski-Lenoir D., Heinrichs S.C., Liu X.J., Ling N., Tucker A., Xie Q., Lappi D.A., Grigoriadis D.E. Selective impairment of corticotropin- releasing factor 1 (CRF 1) receptor-mediated function using CRF coupled to saporin. Endocrinology. 141:2000;498-504.
85. Thorpe P.E., Brown A.N.F., Bremner J.A.G., Foxwell B.M.J., Stirpe F. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. J. Natl. Cancer Inst. 75:1985;151-159.
86. Siena S., Bregni M., Formosa A., Martineau D., Lappi D.A., Bonadonna G., Giaimi A.M. Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation. Transplantation. 46:1988;747-753.
87. DiStefano P.S., Schweitzer J.B., Taniuchi M., Johnson E.M.J. Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor. J. Cell Biol. 101:1985;1107-1114.
88. Ohtake T., Heckers S., Wiley R.G., Lappi D.A., Mesulam M.M., Geula C. Retrograde degeneration and colchicine protection of basal forebrain cholinergic neurons following hippocampal injections of an immunotoxin against the P75 nerve growth factor receptor. Neuroscience. 78:1997;123-133.
89. 3H] hemicholinium-3 to striatal interneurons. Brain Res. 630:1993;169-177.
90. Roberts R.C., Harrison M.B., Francis S.M., Wiley R.G. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons. Exp. Neurol. 124:1993;242-252.
91. de la Cruz R.R., Pastor A.M., Delgado-Garcia J.M. Effects of target depletion on adult mammalian central neurons: functional correlates. Neuroscience. 58:1994;81-97.
92. de la Cruz R.R., Pastor A.M., Delgado-Garcia J.M. Effects of target depletion on adult mammalian central neurons: morphological correlates. Neuroscience. 58:1994;59-79.
93. de la Cruz R.R., Pastor A.M., Delgado-Garcia J.M. Neurotoxic lesion of oculomotor neurons: evidence for rearrangement of axon terminals of surviving afferent neurons. Neurotoxicology. 15:1994;633-636.
94. de la Cruz R.R., Pastor A.M., Delgado-Garcia J.M. Long-term effects of selective target removal on brainstem premotor neurons in the adult cat. Eur. J. Neurosci. 5:1993;232-239.
95. Wrenn C.C., Wiley R.G. The behavioral functions of the cholinergic basal forebrain: lessons from 192 IgG-saporin. Int. J. Dev. Neurosci. 16:1998;595-602.
96. Wreim C.C., Wiley R.G. Lack of effect of moderate Purkinje cell loss on working memory. Neuroscience. 107:2001;433-445.